STRS Ohio’s Werewolf Therapeutics HOWL Stock Holding History
Bought
Maintained
Sold
Other funds holding HOWL
RCM
MAM
MB
PHS
DM
SFM
DF
LCM
STRS Ohio's HOWL Position: Q2 2022 in Review
STRS Ohio sold out of Werewolf Therapeutics (HOWL) in Q2 2022, closing a stake of 1,800 shares — an estimated $7K sold.
STRS Ohio first reported a position in HOWL in Q2 2021 and held it in 4 quarters. The position peaked at $31K in Q2 2021. 46 funds tracked by Wall St. Rank hold HOWL as of Q2 2022.
- STRS Ohio reported no remaining Werewolf Therapeutics position as of Q2 2022 after selling out during the quarter.
- STRS Ohio sold 1,800 Werewolf Therapeutics shares in Q2 2022, an estimated $7K.
- STRS Ohio first reported a position in Werewolf Therapeutics in Q2 2021 and held it in 4 quarters.
- STRS Ohio's Werewolf Therapeutics position peaked at $31K in Q2 2021.
- 46 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q2 2022.
Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.